D13 could also structure new POs with milestone payment structure where first payment to D13 (i.e. cost of building a Mesmer unit or a percentage of Mesmer units for a multiple order) would be due at signing of PO. This would give them the necessary cash flow for manufacturing the units on a PO by PO basis. Just a thought.
- Forums
- ASX - By Stock
- D13
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-9
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add D13 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online